793 related articles for article (PubMed ID: 19447526)
1. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and gene expression profiles of novel synthesized steroid derivatives as chemotherapeutic anti-breast cancer agents.
Elmegeed GA; Khalil WK; Mohareb RM; Ahmed HH; Abd-Elhalim MM; Elsayed GH
Bioorg Med Chem; 2011 Nov; 19(22):6860-72. PubMed ID: 22000946
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
Xie F; Zhao H; Zhao L; Lou L; Hu Y
Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
[TBL] [Abstract][Full Text] [Related]
5. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents.
Ishar MP; Singh G; Singh S; Sreenivasan KK; Singh G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1366-70. PubMed ID: 16332438
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
Rostom SA; Ashour HM; Abd El Razik HA
Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
Ferlin MG; Chiarelotto G; Gasparotto V; Dalla Via L; Pezzi V; Barzon L; Palù G; Castagliuolo I
J Med Chem; 2005 May; 48(9):3417-27. PubMed ID: 15857148
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of polyphenolic extract of Ichnocarpus frutescens.
Kumarappan CT; Mandal SC
Exp Oncol; 2007 Jun; 29(2):94-101. PubMed ID: 17704739
[TBL] [Abstract][Full Text] [Related]
12. In vitro biological evaluation of novel 7-O-dialkylaminoalkyl cytotoxic pectolinarigenin derivatives against a panel of human cancer cell lines.
Bonesi M; Tundis R; Deguin B; Loizzo MR; Menichini F; Tillequin F; Menichini F
Bioorg Med Chem Lett; 2008 Oct; 18(20):5431-4. PubMed ID: 18818071
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-tumor activities of novel methylthio-, sulfinyl-, and sulfonyl-8H-thieno[2,3-b]pyrrolizin-8-oximino derivatives.
Guo S; Zhao Y; Zhao X; Zhang S; Xie L; Kong W; Gong P
Arch Pharm (Weinheim); 2007 Aug; 340(8):416-23. PubMed ID: 17628032
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
16. Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives.
Kumar V; Madaan A; Sanna VK; Vishnoi M; Joshi N; Singh AT; Jaggi M; Sharma PK; Irchhaiya R; Burman AC
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1169-78. PubMed ID: 19555167
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in-vitro cytotoxic evaluation of novel pyridazin-4-one derivatives.
Mojahidi S; Rakib el M; Sekkak H; Abouricha S; Benchat N; Mousse HA; Zyad A
Arch Pharm (Weinheim); 2010 May; 343(5):310-3. PubMed ID: 20222064
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of gibberellin derivatives with anti-tumor bioactivities.
Chen J; Sun Z; Zhang Y; Zeng X; Qing C; Liu J; Li L; Zhang H
Bioorg Med Chem Lett; 2009 Sep; 19(18):5496-9. PubMed ID: 19679470
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
20. Regioselective one-pot synthesis and anti-proliferative and apoptotic effects of some novel tetrazolo[1,5-a]pyrimidine derivatives.
Hussein AM; Ahmed OM
Bioorg Med Chem; 2010 Apr; 18(7):2639-44. PubMed ID: 20227281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]